Press release
Axillary Hyperhidrosis Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Patient Pool, and Companies DelveInsight
Axillary Hyperhidrosis Treatment Market
(Albany, USA) DelveInsight's "Axillary Hyperhidrosis Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Axillary Hyperhidrosis, historical and forecasted epidemiology as well as the Axillary Hyperhidrosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Axillary Hyperhidrosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Axillary Hyperhidrosis Market Forecast [https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Some of the key facts of the Axillary Hyperhidrosis Market Report:
* The Axillary Hyperhidrosis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
* Key Axillary Hyperhidrosis Companies: Botanix Pharmaceuticals, Sound Surgical Technologies, LLC., Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corporation, Person & Covey, Stratus Pharmaceuticals, Journey Medical Corporation, Allergan, AbbVie, Brickell Biotech, Dermavant Sciences, Dermata Therapeutics, Viatris, Candesant Biomedical, and others
* Key Axillary Hyperhidrosis Therapies: Sofpironium Bromide, VASE, Glycopyrronium Bromide, Meditoxin, glycopyrronium Topical Wipesl, and others
* In January 2024, InMode MD Ltd. offers the InMode Pro System with the Morpheus8 Applicator, a computerized device that produces radio frequency energy utilizing Fractional RF technology. The Morpheus8 Applicator, equipped with a 24-pin tip, is specifically designed for treating primary hyperhidrosis in the underarm area.
* There are currently too few and insufficient epidemiologic data on hyperhidrosis to establish accurate prevalence or impact estimates. According to DelveInsight analysts, there were 10,491,560 cases of axillary hyperhidrosis (AH) in the US as a whole
* Based on the HDSS scale, the degree of axillary hyperhidrosis was assessed. According to DelveInsight, 1,584,618 people had non-severe symptoms and roughly 1,716,670 people had severe symptoms in 2021
* In the US, there were 3,301,288 diagnosed cases of axillary hyperhidrosis (AH) overall in 2021.
* The prevalence of primary axillary hyperhidrosis in the population of Japan aged 5-64 years is 5.75% (males, 6.60%; females, 4.72%), according to a study by Murota et al. (2021).
* The Axillary Hyperhidrosis epidemiology based on gender analyzed that in the US, out of the total diagnosed cases of Axillary Hyperhidrosis in 2021, 93% accounted for primary hyperhidrosis and 7% accounted for secondary hyperhidrosis
* The Axillary Hyperhidrosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Axillary Hyperhidrosis pipeline products will significantly revolutionize the Axillary Hyperhidrosis market dynamics.
Axillary Hyperhidrosis Overview
Axillary hyperhidrosis is a condition characterized by excessive sweating in the underarm area, beyond what is necessary for thermoregulation. It is a form of focal hyperhidrosis and typically begins in adolescence or early adulthood. While not life-threatening, the condition can significantly impact quality of life by causing discomfort, social embarrassment, and challenges in daily activities.
The exact cause of axillary hyperhidrosis is not fully understood but is believed to involve overactivity of the eccrine sweat glands, triggered by overstimulation of the sympathetic nervous system. It often occurs without an underlying medical condition but may occasionally be secondary to other disorders like hyperthyroidism or certain medications.
Diagnosis is clinical, based on patient history and physical examination, with additional tests like the iodine-starch test used to assess sweating severity.
Treatment aims to reduce sweating and improve the patient's quality of life. First-line options include topical antiperspirants containing aluminum chloride and prescription-strength formulations. Botulinum toxin (Botox) injections are highly effective for temporary relief. Other interventions include iontophoresis, microwave thermolysis, or surgical procedures like sympathectomy in severe cases. Emerging treatments, such as lasers and topical neurotoxins, offer promising alternatives.
Lifestyle modifications, including wearing breathable fabrics and avoiding triggers, complement medical interventions in managing axillary hyperhidrosis effectively.
Get a Free sample for the Axillary Hyperhidrosis Market Report: Axillary Hyperhidrosis Market Trends [https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-ahh-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr]
Axillary Hyperhidrosis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Axillary Hyperhidrosis Epidemiology Segmentation:
The Axillary Hyperhidrosis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
* Total Prevalence of Axillary Hyperhidrosis
* Prevalent Cases of Axillary Hyperhidrosis by severity
* Gender-specific Prevalence of Axillary Hyperhidrosis
* Diagnosed Cases of Episodic and Chronic Axillary Hyperhidrosis
Download the report to understand which factors are driving Axillary Hyperhidrosis epidemiology trends @ Axillary Hyperhidrosis Epidemiology Forecast [https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Axillary Hyperhidrosis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Axillary Hyperhidrosis market or expected to get launched during the study period. The analysis covers Axillary Hyperhidrosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Axillary Hyperhidrosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Axillary Hyperhidrosis Therapies and Key Companies
* Sofpironium bromide (BBI-4000): Botanix Pharma
* VASER: Sound Surgical Technologies, LLC.
* Glycopyrronium Bromide: Dr. August Wolff GmbH
* Meditoxin: Medy-Tox
* glycopyrronium Topical Wipes: Journey Medical Corporation
Discover more about therapies set to grab major Axillary Hyperhidrosis market share @ Axillary Hyperhidrosis Treatment Market [https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-ahh-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Scope of the Axillary Hyperhidrosis Market Report
* Study Period: 2019-2032
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Axillary Hyperhidrosis Companies: Botanix Pharmaceuticals, Sound Surgical Technologies, LLC., Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corporation, Person & Covey, Stratus Pharmaceuticals, Journey Medical Corporation, Allergan, AbbVie, Brickell Biotech, Dermavant Sciences, Dermata Therapeutics, Viatris, Candesant Biomedical, and others
* Key Axillary Hyperhidrosis Therapies: Sofpironium Bromide, VASE, Glycopyrronium Bromide, Meditoxin, glycopyrronium Topical Wipes, and others
* Axillary Hyperhidrosis Therapeutic Assessment: Axillary Hyperhidrosis current marketed and Axillary Hyperhidrosis emerging therapies
* Axillary Hyperhidrosis Market Dynamics: Axillary Hyperhidrosis market drivers and Axillary Hyperhidrosis market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Axillary Hyperhidrosis Unmet Needs, KOL's views, Analyst's views, Axillary Hyperhidrosis Market Access and Reimbursement
To know more about Axillary Hyperhidrosis companies working in the treatment market, visit @ Axillary Hyperhidrosis Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Table of Contents
1. Axillary Hyperhidrosis Market Report Introduction
2. Executive Summary for Axillary Hyperhidrosis
3. SWOT analysis of Axillary Hyperhidrosis
4. Axillary Hyperhidrosis Patient Share (%) Overview at a Glance
5. Axillary Hyperhidrosis Market Overview at a Glance
6. Axillary Hyperhidrosis Disease Background and Overview
7. Axillary Hyperhidrosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Axillary Hyperhidrosis
9. Axillary Hyperhidrosis Current Treatment and Medical Practices
10. Axillary Hyperhidrosis Unmet Needs
11. Axillary Hyperhidrosis Emerging Therapies
12. Axillary Hyperhidrosis Market Outlook
13. Country-Wise Axillary Hyperhidrosis Market Analysis (2019-2032)
14. Axillary Hyperhidrosis Market Access and Reimbursement of Therapies
15. Axillary Hyperhidrosis Market Drivers
16. Axillary Hyperhidrosis Market Barriers
17. Axillary Hyperhidrosis Appendix
18. Axillary Hyperhidrosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=axillary-hyperhidrosis-treatment-market-2032-clinical-trials-ema-pdma-fda-approvals-medication-patient-pool-and-companies-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/conference-coverage-services
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Axillary Hyperhidrosis Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Patient Pool, and Companies DelveInsight here
News-ID: 3785181 • Views: …
More Releases from ABNewswire
Gastroparesis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, an …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Gastroparesis pipeline constitutes 10+ key companies continuously working towards developing 11+ Gastroparesis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Gastroparesis Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/gastroparesis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Gastroparesis Market.
The Gastroparesis Pipeline report embraces in-depth commercial and clinical…
Five Star Painting of Tampa Bay Delivers Residential Painting Services Backed by …
Tampa, FL - Five Star Painting of Tampa Bay [https://www.fivestarpainting.com/tampa-bay/residential/] provides professional residential painting services across the Tampa Bay area, focusing on both interior and exterior projects. With a range of offerings that include cabinet painting, deck refinishing, and custom interior painting, the company aims to enhance the functionality and aesthetics of local homes. Backed by a two-year warranty, their services are designed to deliver reliable results tailored to meet…
Giant-Cell Arteritis Pipeline Update 2024: FDA Approvals, Therapeutic Advancemen …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Giant-Cell Arteritis pipeline constitutes 6+ key companies continuously working towards developing 6+ Giant-Cell Arteritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Giant-Cell Arteritis Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/giant-cell-arteritis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Giant-Cell Arteritis Market.
The Giant-Cell Arteritis Pipeline report…
Esophageal Cancer Pipeline Assessment 2024: Therapies, Clinical Trials, Latest F …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Esophageal Cancer pipeline constitutes 80+ key companies continuously working towards developing 100+ Esophageal Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Esophageal Cancer Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/esophageal-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Esophageal Cancer Market.
The Esophageal Cancer Pipeline report…
More Releases for Axillary
Massive Growth in Axillary Crutches Market, 2021-2026
(Portland, United States): Big Market Research newly added a research report on the Axillary Crutches Market which represents a study for the period from 2021 to 2026. The research study provides a near look at the market scenario and dynamics impacting its growth. This report highlights the crucial developments along with other events happening in the market which are marking on the growth and opening doors for future growth in…
Axillary Crutches Market - Size, Share, Outlook, and Opportunity
Axillary crutches are the mobility aids used by individuals suffering from walking disability, factures, paralysis, and leg injuries. Axillary crutches transfer the weight from legs to the arms/shoulders and support the movement of individuals who are unable to walk due to some disability. Axillary crutches are lightweight and they are available in various materials, which includes aluminum, stainless steel, and wooden. Axillary crutches are adjustable in size and can be…
Axillary Hyperhidrosis Pharmaceutical and Healthcare Analysis Information
Summary
Axillary hyperhidrosis also referred to as excessive underarm sweating. Excessive sweating in the affected area is caused by over activity of the nerves linked to the sweat glands. Specifically, acetylcholine, a chemical in the body that transmits nerve signals, is released from nerve endings and stimulates secretion of sweat. The condition most frequently develops in adolescence or young adulthood. Treatment includes anticholinergic drugs, surgery and antiperspirants.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3079814-axillary-hyperhidrosis-pipeline-review-h1-2018…
Axillary Hyperhidrosis - Pipeline Research and Markets Insight, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Axillary Hyperhidrosis - Pipeline Insight, 2017”. This report provides comprehensive insights of the ongoing therapeutic research and development across Axillary Hyperhidrosis.
Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265422
The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Axillary Hyperhidrosis by development stage, therapy…
Global Axillary Crutches Market: Top Players - Invacare, Stander, Sizewise
Latest industry research report on: Global Axillary Crutches Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1001065
This report studies sales (consumption) of Axillary Crutches in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Millennial Medical
Ergoactives
Cardinal Health
AMG Medical Inc/Airgo
Carex
Graham Field
Nova…
Global Axillary Crutches Market Research Report 2017
Report Hive Market Research Released a New Research Report of 102 pages on Title " Global Axillary Crutches Market Research Report 2017 "with detailed Analysis, Forecast and Strategies.
In this report, the global Axillary Crutches market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented…
